BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong YQ, Lu CW, Zhang L, Yang J, Hameed W, Chen W. Toll-like receptor 4 signaling promotes invasion of hepatocellular carcinoma cells through MKK4/JNK pathway. Mol Immunol. 2015;68:671-683. [PMID: 26589455 DOI: 10.1016/j.molimm.2015.10.015] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Yang W, Gao S, Wang Z, Pan L, Luo X, Zhang Y. The upregulation of microRNA-223 promoted the apoptosis of liver cancer cells via TLR4. All Life 2020;13:598-607. [DOI: 10.1080/26895293.2020.1835743] [Reference Citation Analysis]
2 Wee JH, Ko YK, Khalmuratova R, Shin HW, Kim DW, Rhee CS. Effect of lipopolysaccharide and polyinosinic:polycytidylic acid in a murine model of nasal polyp. Sci Rep 2021;11:1021. [PMID: 33441902 DOI: 10.1038/s41598-020-80483-y] [Reference Citation Analysis]
3 Tang Y, Cao Q, Guo X, Dong S, Duan J, Wu Q, Liang Q. Inhibition of p38 and ERK1/2 pathways by Sparstolonin B suppresses inflammation-induced melanoma metastasis. Biomedicine & Pharmacotherapy 2018;98:382-9. [DOI: 10.1016/j.biopha.2017.12.047] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
4 Sadangi S, Mohanty A, Paichha M, Samanta M. Molecular characterization and expression analysis of two crucial MAPKs- jnk1 and erk1 as cellular signal transducers in Labeo rohita in response to PAMPs stimulation and pathogenic invasion. J Fish Biol 2020;96:580-9. [PMID: 31886519 DOI: 10.1111/jfb.14244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yu WC, Cong JP, Mi LY. Expressions of TOLL-like receptor 4 (TLR-4) and matrix metalloproteinase 9 (MMP-9)/Tissue inhibitor of metalloproteinase 1 (TIMP-1) in pulmonary blood vessels with chronic obstructive pulmonary diseases and their relationships with pulmonary vascular remodelling. Rev Assoc Med Bras (1992) 2018;64:361-7. [PMID: 30133616 DOI: 10.1590/1806-9282.64.04.361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Sepehri Z, Kiani Z, Kohan F, Alavian SM, Ghavami S. Toll like receptor 4 and hepatocellular carcinoma; A systematic review. Life Sci 2017;179:80-7. [PMID: 28472619 DOI: 10.1016/j.lfs.2017.04.025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
7 Li H, Bai S, Ao Q, Wang X, Tian X, Li X, Tong H, Hou W, Fan J. Modulation of Immune-Inflammatory Responses in Abdominal Aortic Aneurysm: Emerging Molecular Targets. J Immunol Res 2018;2018:7213760. [PMID: 29967801 DOI: 10.1155/2018/7213760] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
8 Xu Q, Li T, Chen H, Kong J, Zhang L, Yin H. Design and optimisation of a small-molecule TLR2/4 antagonist for anti-tumour therapy. RSC Med Chem 2021;12:1771-9. [PMID: 34778778 DOI: 10.1039/d1md00175b] [Reference Citation Analysis]
9 Brennan A, Leech JT, Kad NM, Mason JM. Selective antagonism of cJun for cancer therapy. J Exp Clin Cancer Res 2020;39:184. [PMID: 32917236 DOI: 10.1186/s13046-020-01686-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Lurje I, Werner W, Mohr R, Roderburg C, Tacke F, Hammerich L. In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma. Front Immunol 2021;12:650486. [PMID: 34025657 DOI: 10.3389/fimmu.2021.650486] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Chan KK, Leung CO, Wong CC, Ho DW, Chok KS, Lai CL, Ng IO, Lo RC. Secretory Stanniocalcin 1 promotes metastasis of hepatocellular carcinoma through activation of JNK signaling pathway. Cancer Lett 2017;403:330-8. [PMID: 28688970 DOI: 10.1016/j.canlet.2017.06.034] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
12 Shi G, Wang C, Zhang P, Ji L, Xu S, Tan X, Li H. Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation. Arch Med Res 2017;48:553-60. [PMID: 29221801 DOI: 10.1016/j.arcmed.2017.11.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
13 Suzuki M, Ramezanpour M, Cooksley C, Li J, Nakamaru Y, Homma A, Psaltis A, Wormald PJ, Vreugde S. Sirtuin-1 Controls Poly (I:C)-Dependent Matrix Metalloproteinase 9 Activation in Primary Human Nasal Epithelial Cells. Am J Respir Cell Mol Biol 2018;59:500-10. [PMID: 29767533 DOI: 10.1165/rcmb.2017-0415OC] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
14 Yang S, Wang Y, Ren Z, Chen M, Chen W, Zhang X. Stepwise pH/reduction-responsive polymeric conjugates for enhanced drug delivery to tumor. Materials Science and Engineering: C 2018;82:234-43. [DOI: 10.1016/j.msec.2017.08.079] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
15 Qu N, Meng Y, Handley MK, Wang C, Shan F. Preclinical and clinical studies into the bioactivity of low-dose naltrexone (LDN) for oncotherapy. Int Immunopharmacol 2021;96:107714. [PMID: 33989971 DOI: 10.1016/j.intimp.2021.107714] [Reference Citation Analysis]
16 Bai R, Yuan C, Zhou F, Ni L, Gong Y, Xie C. Evaluation of the association between the -1304T>G polymorphism in the promoter of the MKK4 gene and the risk of colorectal cancer: a PRISMA-compliant meta-analysis. Ann Transl Med 2019;7:144. [PMID: 31157265 DOI: 10.21037/atm.2019.03.08] [Reference Citation Analysis]
17 Wu Q, Wu W, Fu B, Shi L, Wang X, Kuca K. JNK signaling in cancer cell survival. Med Res Rev 2019;39:2082-104. [PMID: 30912203 DOI: 10.1002/med.21574] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 18.0] [Reference Citation Analysis]
18 Yang S, Ren Z, Chen M, Wang Y, You B, Chen W, Qu C, Liu Y, Zhang X. Nucleolin-Targeting AS1411-Aptamer-Modified Graft Polymeric Micelle with Dual pH/Redox Sensitivity Designed To Enhance Tumor Therapy through the Codelivery of Doxorubicin/TLR4 siRNA and Suppression of Invasion. Mol Pharm 2018;15:314-25. [PMID: 29250957 DOI: 10.1021/acs.molpharmaceut.7b01093] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
19 Huang C, Zhang H, Bai R, Wang L, Lv J. A896G and C1196T Polymorphisms Within the TLR4 Gene Abate Toll-Like Receptor 4-Mediated Signaling in HepG2 Cells. DNA Cell Biol 2017;36:1029-38. [PMID: 28945461 DOI: 10.1089/dna.2017.3892] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
20 Katsukawa M, Ohsawa S, Zhang L, Yan Y, Igaki T. Serpin Facilitates Tumor-Suppressive Cell Competition by Blocking Toll-Mediated Yki Activation in Drosophila. Current Biology 2018;28:1756-1767.e6. [DOI: 10.1016/j.cub.2018.04.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
21 Moretti IF, Lerario AM, Trombetta-Lima M, Sola PR, da Silva Soares R, Oba-Shinjo SM, Marie SKN. Late p65 nuclear translocation in glioblastoma cells indicates non-canonical TLR4 signaling and activation of DNA repair genes. Sci Rep 2021;11:1333. [PMID: 33446690 DOI: 10.1038/s41598-020-79356-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Maguire EM, Pearce SWA, Xiao R, Oo AY, Xiao Q. Matrix Metalloproteinase in Abdominal Aortic Aneurysm and Aortic Dissection. Pharmaceuticals (Basel) 2019;12:E118. [PMID: 31390798 DOI: 10.3390/ph12030118] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 11.7] [Reference Citation Analysis]
23 Wu MH, Chiu YF, Wu WJ, Wu PL, Lin CY, Lin CL, Hsieh YH, Liu CJ. Synergistic antimetastatic effect of cotreatment with licochalcone A and sorafenib on human hepatocellular carcinoma cells through the inactivation of MKK4/JNK and uPA expression. Environ Toxicol 2018;33:1237-44. [PMID: 30187994 DOI: 10.1002/tox.22630] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
24 Wang J, Tai G. Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development. Target Oncol 2016;11:723-38. [PMID: 27392951 DOI: 10.1007/s11523-016-0446-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
25 Jain S, Dash P, Minz AP, Satpathi S, Samal AG, Behera PK, Satpathi PS, Senapati S. Lipopolysaccharide (LPS) enhances prostate cancer metastasis potentially through NF‐κB activation and recurrent dexamethasone administration fails to suppress it in vivo. Prostate 2018;79:168-82. [DOI: 10.1002/pros.23722] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
26 Bi Y, Mao Y, Su Z, Du J, Ye L, Xu F. Long noncoding RNA HNF1A-AS1 regulates proliferation and apoptosis of glioma through activation of the JNK signaling pathway via miR-363-3p/MAP2K4. J Cell Physiol 2021;236:1068-82. [PMID: 32779194 DOI: 10.1002/jcp.29916] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
27 Alvarado-Tapias E, Guarner-Argente C, Oblitas E, Sánchez E, Vidal S, Román E, Concepción M, Poca M, Gely C, Pavel O, Nieto JC, Juárez C, Guarner C, Soriano G. Toll-like receptor 4 polymorphisms and bacterial infections in patients with cirrhosis and ascites. World J Hepatol 2018; 10(1): 124-133 [PMID: 29399286 DOI: 10.4254/wjh.v10.i1.124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Liang HW, Ye ZH, Yin SY, Mo WJ, Wang HL, Zhao JC, Liang GM, Feng ZB, Chen G, Luo DZ. A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma. Onco Targets Ther 2017;10:3405-19. [PMID: 28744145 DOI: 10.2147/OTT.S138143] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]